Quarterly report pursuant to Section 13 or 15(d)

Schedule of Diluted Net Loss Per Share (Details)

v3.24.1.1.u2
Schedule of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Warrants 260,213 690,000